S6K inhibition restores growth-factor-stimulated AKT signaling in B56γ3-depleted SW480 cells
Cell-based study · SW480 colorectal cancer cells: shLuc control versus B56γ3 knockdown (shB56γ3) [1]
At 5 μM, LY-2584702 reduced downstream S6 phosphorylation and restored IGF-1-stimulated AKT phosphorylation in B56γ3-depleted cells. p70S6K Thr389 phosphorylation was not reduced. This supports a feedback response in this defined cellular context, rather than uniform suppression of upstream AKT.
| Endpoint | Reported result | Reference |
|---|---|---|
| S6 phosphorylation at Ser240/244 | qualitative immunoblot response Reduced with LY-2584702 versus B56γ3-knockdown vehicle condition; no numerical effect size extracted. | [1] |
| AKT phosphorylation at Thr308 and Ser473 | qualitative immunoblot response Restored by LY-2584702 in growth-factor-stimulated B56γ3-depleted cells compared with DMSO-treated knockdown cells. | [1] |
| p70S6K phosphorylation at Thr389 | qualitative immunoblot response Not reduced by LY-2584702 in this experiment. | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 5 μM LY-2584702; IGF-1 stimulation at 50 ng/ml
- Exposure duration
- Pretreatment followed by 60 min IGF-1 stimulation with LY-2584702 present; drug pretreatment interval not specified in Fig. 3J.
- Method
- Cellular treatment followed by SDS-PAGE and Western blotting.
- Vehicle
- DMSO control; vehicle concentration not specified for Fig. 3J.
- Co-treatment
- IGF-1 is the signaling stimulus; no second pharmacological inhibitor in adopted panel J.
- Reported limits
- Pretreatment interval, drug lot, catalog number, salt form and DMSO fraction are not specified for the adopted experiment.
Methods and source locations
Compound reported in the paper: LY-2584702; Compound label in the paper: LY-2584702 (Adooq Bioscience), as named in Fig. 3J
Reported cellular behavior of LY-2584702; not a certificate of free-base form, purity or current-lot performance.
Fig. 3J, caption and image; Results Sec17 LY-2584702 rescue paragraph; Methods Sec6 and Sec14
S6 phosphorylation at Ser240/244: SDS-PAGE/Western blot; total S6 and β-actin controls visible. — Fig. 3J, caption and image; Results Sec17 LY-2584702 rescue paragraph; Methods Sec6 and Sec14
AKT phosphorylation at Thr308 and Ser473: Western blot, total AKT control and relative phospho-AKT quantification; caption reports n = 3 independent experiments for quantification. — Fig. 3J, caption and image; Results Sec17 LY-2584702 rescue paragraph; Methods Sec6 and Sec14
p70S6K phosphorylation at Thr389: Western blot with total p70S6K control; pathway output assessed separately by phospho-S6. — Fig. 3J, caption and image; Results Sec17 LY-2584702 rescue paragraph; Methods Sec6 and Sec14